Guidelines recommend semi-annual HCC screening using abdominal ultrasound with or without alpha-fetoprotein (AFP) in high-risk individuals, including those with non-cirrhotic hepatitis B infection or cirrhosis from any etiology.3 The gene discussed is AFP; the disease is hepatocellular carcinoma.